Autocrine regulation of insulin secretion

Diabetes, Obesity and Metabolism

Volumn 14, Issue SUPPL.3, 2012, Pages 143-151

  Braun, M ^a,b   Ramracheya, R ^c   Rorsman, P ^c,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ATP; Autocrine; Electrophysiology; GABA; Insulin secretion; Zinc

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; AMYLIN; CHROMOGRANIN A; CHROMOGRANIN B; INSULIN; NEUROPEPTIDE Y; SOMATOMEDIN B; ZINC;

AUTOCRINE EFFECT; CELL PROLIFERATION; CELL SYNCHRONIZATION; EXOCYTOSIS; GENETIC TRANSCRIPTION; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; MEMBRANE POTENTIAL; NONHUMAN; PANCREAS ISLET BETA CELL; PULSATILE FLOW; REVIEW; VELOCITY;

EID: 84865610004     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2012.01642.x     Document Type: Review

References (99)

1. Gurdon JB, Lemaire P, Kato K. Community effects and related phenomena in development. Cell 1993; 75: 831-834.
2. Moos F. Autocrine control of neuronal excitability. J Physiol 2004; 558: 2.
3. Frerichs H, Reich U, Creutzfeldt W. Insulin secretion in vitro. I. Inhibition of glucose-induced insulin release by insulin. Klin Wochenschr 1965; 43: 136-140.
4. Leibiger IB, Leibiger B, Berggren PO. Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr 2008; 28: 233-251.
5. Ammon HP, Reiber C, Verspohl EJ. Indirect evidence for short-loop negative feedback of insulin secretion in the rat. J Endocrinol 1991; 128: 27-34.
6. Aspinwall CA, Lakey JR, Kennedy RT. Insulin-stimulated insulin secretion in single pancreatic beta cells. J Biol Chem 1999; 274: 6360-6365.
7. Zawalich WS, Zawalich KC. Effects of glucose, exogenous insulin, and carbachol on C-peptide and insulin secretion from isolated perifused rat islets. J Biol Chem 2002; 277: 26233-26237.
8. Jimenez-Feltstrom J, Lundquist I, Obermuller S, Salehi A. Insulin feedback actions: complex effects involving isoforms of islet nitric oxide synthase. Regul Pept 2004; 122: 109-118.
9. Park SH, Kim SY, Baek WK et al. Regulation of glucose-dependent insulin secretion by insulin: possible role of AMP-activated protein kinase. Life Sci 2009; 85: 178-183.
10. Jonas JC, Plant TD, Gilon P et al. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Br J Pharmacol 1995; 114: 872-880.
11. Johnson JD, Misler S. Nicotinic acid-adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human beta cells. Proc Natl Acad Sci U S A 2002; 99: 14566-14571.
12. Luciani DS, Johnson JD. Acute effects of insulin on beta-cells from transplantable human islets. Mol Cell Endocrinol 2005; 241: 88-98.
13. Persaud SJ, Asare-Anane H, Jones PM. Insulin receptor activation inhibits insulin secretion from human islets of Langerhans. FEBS Lett 2002; 510: 225-228.
14. Persaud SJ, Muller D, Jones PM. Insulin signalling in islets. Biochem Soc Trans 2008; 36: 290-293.
15. Khan FA, Goforth PB, Zhang M, Satin LS. Insulin activates ATP-sensitive K(+) channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes 2001; 50: 2192-2198.
16. Hagren OI, Tengholm A. Glucose and insulin synergistically activate phosphatidylinositol 3-kinase to trigger oscillations of phosphatidylinositol 3, 4, 5-trisphosphate in beta-cells. J Biol Chem 2006; 281: 39121-39127.
17. Kahn SE, D'Alessio DA, Schwartz MW et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 1990; 39: 634-638.
18. Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev 2011; 91: 795-826.
19. Akesson B, Panagiotidis G, Westermark P, Lundquist I. Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets. Regul Pept 2003; 111: 55-60.
20. Wang ZL, Bennet WM, Ghatei MA et al. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 1993; 42: 330-335.
21. Gebre-Medhin S, Mulder H, Pekny M et al. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun 1998; 250: 271-277.
22. Ahren B, Oosterwijk C, Lips CJ, Hoppener JW. Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice. Diabetologia 1998; 41: 1374-1380.
23. Martinez A, Kapas S, Miller MJ, Ward Y, Cuttitta F. Coexpression of receptors for adrenomedullin, calcitonin gene-related peptide, and amylin in pancreatic beta-cells. Endocrinology 2000; 141: 406-411.
24. Muff R, Buhlmann N, Fischer JA, Born W. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology 1999; 140: 2924-2927.
25. Wagoner PK, Chen C, Worley JF, Dukes ID, Oxford GS. Amylin modulates beta-cell glucose sensing via effects on stimulus-secretion coupling. Proc Natl Acad Sci U S A 1993; 90: 9145-9149.
26. Zhu T, Wang Y, He B et al. Islet amyloid polypeptide acts on glucose-stimulated beta cells to reduce voltage-gated calcium channel activation, intracellular Ca(2+) concentration, and insulin secretion. Diabetes Metab Res Rev 2011; 27: 28-34.
27. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 2003; 348: 1134-1149.
28. Ahren B, Bertrand G, Roye M, Ribes G. Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas. Acta Physiol Scand 1996; 158: 63-70.
29. Ahren B, Pierzynowski SG, Westrom B, Karlsson B. Pancreastatin inhibits insulin secretion and exocrine pancreatic secretion in the pig. Diabetes Res 1990; 14: 93-96.
30. Efendic S, Tatemoto K, Mutt V et al. Pancreastatin and islet hormone release. Proc Natl Acad Sci U S A 1987; 84: 7257-7260.
31. Tatemoto K, Efendic S, Mutt V et al. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986; 324: 476-478.
32. Karlsson E, Stridsberg M, Sandler S. Chromogranin-B regulation of IAPP and insulin secretion. Regul Pept 2000; 87: 33-39.
33. Ma HT, Kato M, Tatemoto K. Effects of pancreastatin and somatostatin on secretagogues-induced rise in intracellular free calcium in single rat pancreatic islet cells. Regul Pept 1996; 61: 143-148.
34. Sanchez-Margalet V, Gonzalez-Yanes C, Najib S, Santos-Alvarez J. Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin. Regul Pept 2010; 161: 8-14.
35. Schmid GM, Meda P, Caille D et al. Inhibition of insulin secretion by betagranin, an N-terminal chromogranin A fragment. J Biol Chem 2007; 282: 12717-12724.
36. Portela-Gomes GM, Hoog A. Insulin-like growth factor II in human fetal pancreas and its co-localization with the major islet hormones: comparison with adult pancreas. J Endocrinol 2000; 165: 245-251.
37. Cornu M, Yang JY, Jaccard E et al. Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop. Diabetes 2009; 58: 1816-1825.
38. Leahy JL, Vandekerkhove KM. Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 1990; 126: 1593-1598.
39. Zhang Q, Berggren PO, Larsson O, Hall K, Tally M. Insulin-like growth factor II inhibits glucose-induced insulin exocytosis. Biochem Biophys Res Commun 1998; 243: 117-121.
40. Zhang Q, Tally M, Larsson O et al. Insulin-like growth factor II signaling through the insulin-like growth factor II/mannose-6-phosphate receptor promotes exocytosis in insulin-secreting cells. Proc Natl Acad Sci U S A 1997; 94: 6232-6237.
41. Dheen ST, Rajkumar K, Murphy LJ. Effects of insulin-like growth factors (IGF) on pancreatic islet function in IGF binding protein-1 transgenic mice. Diabetologia 1996; 39: 1249-1254.
42. Buchanan CM, Phillips AR, Cooper GJ. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochem J 2001; 360: 431-439.
43. Wang ZL, Bennet WM, Wang RM, Ghatei MA, Bloom SR. Evidence of a paracrine role of neuropeptide-Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone-treated rats. Endocrinology 1994; 135: 200-206.
44. Moltz JH, McDonald JK. Neuropeptide Y: direct and indirect action on insulin secretion in the rat. Peptides 1985; 6: 1155-1159.
45. Alwmark A, Ahren B. Phentolamine reverses NPY-induced inhibition of insulin secretion in isolated rat islets. Eur J Pharmacol 1987; 135: 307-311.
46. Kulkarni RN, Wang ZL, Wang RM et al. Glibenclamide but not other sulphonylureas stimulates release of neuropeptide Y from perifused rat islets and hamster insulinoma cells. J Endocrinol 2000; 165: 509-518.
47. Whim MD. Pancreatic beta cells synthesize neuropeptide Y and can rapidly release peptide co-transmitters. PLoS One 2011; 6: e19478.
48. Myrsen-Axcrona U, Ekblad E, Sundler F. Developmental expression of NPY, PYY and PP in the rat pancreas and their coexistence with islet hormones. Regul Pept 1997; 68: 165-175.
49. Waeber G, Calandra T, Roduit R et al. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci U S A 1997; 94: 4782-4787.
50. Portela-Gomes GM, Lukinius A, Ljungberg O et al. PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas. Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets. Regul Pept 2003; 113: 31-39.
51. Suckale J, Solimena M. The insulin secretory granule as a signaling hub. Trends Endocrinol Metab 2010; 21: 599-609.
52. Leitner JW, Sussman KE, Vatter AE, Schneider FH. Adenine nucleotides in the secretory granule fraction of rat islets. Endocrinology 1975; 96: 662-677.
53. Hazama A, Hayashi S, Okada Y. Cell surface measurements of ATP release from single pancreatic beta cells using a novel biosensor technique. Pflugers Arch 1998; 437: 31-35.
54. Obermuller S, Lindqvist A, Karanauskaite J et al. Selective nucleotide-release from dense-core granules in insulin-secreting cells. J Cell Sci 2005; 118: 4271-4282.
55. Braun M, Wendt A, Karanauskaite J et al. Corelease and differential exit via the fusion pore of GABA, serotonin, and ATP from LDCV in rat pancreatic beta cells. J Gen Physiol 2007; 129: 221-231.
56. Petit P, Lajoix AD, Gross R. P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology. Eur J Pharm Sci 2009; 37: 67-75.
57. Bertrand G, Gross R, Chapal J, Loubatieres-Mariani MM. Difference in the potentiating effect of adenosine triphosphate and alpha, beta-methylene ATP on the biphasic insulin response to glucose. Br J Pharmacol 1989; 98: 998-1004.
58. Loubatieres-Mariani MM, Chapal J, Lignon F, Valette G. Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. Eur J Pharmacol 1979; 59: 277-286.
59. Poulsen CR, Bokvist K, Olsen HL et al. Multiple sites of purinergic control of insulin secretion in mouse pancreatic beta-cells. Diabetes 1999; 48: 2171-2181.
60. Salehi A, Qader SS, Grapengiesser E, Hellman B. Inhibition of purinoceptors amplifies glucose-stimulated insulin release with removal of its pulsatility. Diabetes 2005; 54: 2126-2131.
61. Grapengiesser E, Dansk H, Hellman B. Pulses of external ATP aid to the synchronization of pancreatic beta-cells by generating premature Ca(2+) oscillations. Biochem Pharmacol 2004; 68: 667-674.
62. Li GD, Milani D, Dunne MJ et al. Extracellular ATP causes Ca2(+)-dependent and -independent insulin secretion in RINm5F cells. Phospholipase C mediates Ca2+ mobilization but not Ca2+ influx and membrane depolarization. J Biol Chem 1991; 266: 3449-3457.
63. Xie L, Zhang M, Zhou W et al. Extracellular ATP stimulates exocytosis via localized Ca(2+) release from acidic stores in rat pancreatic beta cells. Traffic 2006; 7: 429-439.
64. Verspohl EJ, Johannwille B, Waheed A, Neye H. Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets. Can J Physiol Pharmacol 2002; 80: 562-568.
65. Fernandez-Alvarez J, Hillaire-Buys D, Loubatieres-Mariani MM, Gomis R, Petit P. P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas 2001; 22: 69-71.
66. Jacques-Silva MC, Correa-Medina M, Cabrera O et al. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc Natl Acad Sci U S A 2010; 107: 6465-6470.
67. Braun M, Ramracheya R, Bengtsson M et al. Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells. Diabetes 2010; 59: 1694-1701.
68. Reetz A, Solimena M, Matteoli M et al. GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 1991; 10: 1275-1284.
69. Braun M, Wendt A, Birnir B et al. Regulated exocytosis of GABA-containing synaptic-like microvesicles in pancreatic beta-cells. J Gen Physiol 2004; 123: 191-204.
70. Smismans A, Schuit F, Pipeleers D. Nutrient regulation of gamma-aminobutyric acid release from islet beta cells. Diabetologia 1997; 40: 1411-1415.
71. Braun M, Wendt A, Buschard K et al. GABAB receptor activation inhibits exocytosis in rat pancreatic beta-cells by G-protein-dependent activation of calcineurin. J Physiol 2004; 559: 397-409.
72. Bonaventura MM, Catalano PN, Chamson-Reig A et al. GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice. Am J Physiol Endocrinol Metab 2008; 294: E157-E167.
73. Taneera J, Jin Z, Jin Y et al. Gamma-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes. Diabetologia 2012; 55: 1985-1994.
74. Dong H, Kumar M, Zhang Y et al. Gamma-aminobutyric acid up- and downregulates insulin secretion from beta cells in concert with changes in glucose concentration. Diabetologia 2006; 49: 697-705.
75. Soltani N, Qiu H, Aleksic M et al. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc Natl Acad Sci U S A 2011; 108: 11692-11697.
76. Wijesekara N, Chimienti F, Wheeler MB. Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab 2009; 11(Suppl. 4): 202-214.
77. Popovics P, Stewart AJ. GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol Life Sci 2011; 68: 85-95.
78. Davies PA, Wang W, Hales TG, Kirkness EF. A novel class of ligand-gated ion channel is activated by Zn2+. J Biol Chem 2003; 278: 712-717.
79. Mathie A, Sutton GL, Clarke CE, Veale EL. Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability. Pharmacol Ther 2006; 111: 567-583.
80. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 2003; 5: 330-335.
81. Sladek R, Rocheleau G, Rung J et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881-885.
82. Rutter GA. Think zinc: new roles for zinc in the control of insulin secretion. Islets 2010; 2: 49-50.
83. Wijesekara N, Dai FF, Hardy AB et al. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 2010; 53: 1656-1668.
84. Richards-Williams C, Contreras JL, Berecek KH, Schwiebert EM. Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion. Purinergic Signal 2008; 4: 393-405.
85. Huang L, Shen H, Atkinson MA, Kennedy RT. Detection of exocytosis at individual pancreatic beta cells by amperometry at a chemically modified microelectrode. Proc Natl Acad Sci U S A 1995; 92: 9608-9612.
86. Hutton JC, Penn EJ, Peshavaria M. Low-molecular weight constituents of isolated insulin-secretory granules. Biochem J 1983; 210: 297-305.
87. Galvanovskis J, Braun M, Rorsman P. Exocytosis from pancreatic beta-cells: mathematical modeling of the exit of low-molecular weight granule content. Interface Focus 2011; 1: 143-152.
88. Magzoub M, Zhang H, Dix JA, Verkman AS. Extracellular space volume measured by two-color pulsed dye infusion with microfiberoptic fluorescence photodetection. Biophys J 2009; 96: 2382-2390.
89. Henquin JC, Dufrane D, Nenquin M. Nutrient control of insulin secretion in isolated normal human islets. Diabetes 2006; 55: 3470-3477.
90. Ravier MA, Guldenagel M, Charollais A et al. Loss of connexin36 channels alters beta-cell coupling, islet synchronization of glucose-induced Ca2+ and insulin oscillations, and basal insulin release. Diabetes 2005; 54: 1798-1807.
91. Hellman B, Dansk H, Grapengiesser E. Pancreatic beta-cells communicate via intermittent release of ATP. Am J Physiol Endocrinol Metab 2004; 286: E759-E765.
92. Hellman B, Salehi A, Gylfe E, Dansk H, Grapengiesser E. Glucose generates coincident insulin and somatostatin pulses and antisynchronous glucagon pulses from human pancreatic islets. Endocrinology 2009; 150: 5334-5340.
93. Tengholm A, Gylfe E. Oscillatory control of insulin secretion. Mol Cell Endocrinol 2009; 297: 58-72.
94. Gilon P, Ravier MA, Jonas JC, Henquin JC. Control mechanisms of the oscillations of insulin secretion in vitro and in vivo. Diabetes 2002; 51(Suppl. 1): S144-S151.
95. Quesada I, Todorova MG, Alonso-Magdalena P et al. Glucose induces opposite intracellular Ca2+ concentration oscillatory patterns in identified alpha- and beta-cells within intact human islets of Langerhans. Diabetes 2006; 55: 2463-2469.
96. Macdonald PE, Rorsman P. The ins and outs of secretion from pancreatic β-cells: control of single-vesicle exo- and endocytosis. Physiology 2007; 22: 113-121.
97. MacDonald PE, Braun M, Galvanovskis J, Rorsman P. Release of small transmitters through kiss-and-run fusion pores in rat pancreatic beta cells. Cell Metab 2006; 4: 283-290.
98. Rutter GA, Tsuboi T. Kiss and run exocytosis of dense core secretory vesicles. Neuroreport 2004; 15: 79-81.
99. Hoppa MB, Jones E, Karanauskaite J et al. Multivesicular exocytosis in rat pancreatic beta cells. Diabetologia 2012; 55: 1001-1012.